Heterocyclic Potassium Channel Modulators for Neurological Disorders
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for diseases involving potassium channels lack effective modulators that can specifically target voltage-dependent potassium channels to manage conditions such as epilepsy, pain, and neurological disorders.
Innovation Solution
Development of novel heterocyclic compounds that act as potassium channel modulators, specifically targeting voltage-dependent potassium channels to increase ion flow and treat central or peripheral nervous system disorders by administering effective amounts of these compounds.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current treatments for diseases involving potassium channels are used, then existing therapeutic approaches are maintained, but effective modulators that can specifically target voltage-dependent potassium channels are lacking
Solution Approach 1:
The patent applies parameter changes by developing novel heterocyclic compounds with specific molecular structures (Formula I) that have distinct chemical properties compared to existing treatments. These structural parameters (ring systems, substituents R1-R6) are optimized to achieve specific binding to voltage-dependent potassium channels, thereby improving both therapeutic effectiveness and channel specificity simultaneously
2Reliability
If novel heterocyclic compounds are developed to specifically target voltage-dependent potassium channels, then specificity and therapeutic effectiveness are improved, but the complexity of drug development and characterization increases
Solution Approach 1:
The patent applies segmentation by dividing the complex heterocyclic compound into distinct structural modules (core heterocyclic ring system with variable substituents R1-R6). This modular structure allows systematic optimization of specific components while maintaining overall therapeutic effectiveness, thereby managing development complexity through structured design
Solution Approach 2:
The patent applies universality by creating a broad class of heterocyclic compounds (Formula I) that can target multiple voltage-dependent potassium channels (Kv1.1-Kv1.6, Kv2.1-Kv2.3, Kv3.1-Kv3.3) with a single structural framework. This multi-functional approach allows one compound class to address various neurological conditions, reducing overall development complexity compared to creating separate targeted therapies for each channel
Data Source
AI summary
Compounds, compositions and methods are provided which are useful in the treatment of diseases through the modulation of potassium ion flux through voltage-dependent potassium channels. More particularly, the invention provides heterocycles, compositions and methods that are useful in the treatment of central or peripheral nervous system disorders (e.g., migraine, ataxia, Parkinson's disease, bipolar disorders, trigeminal neuralgia, spasticity, mood disorders, brain tumors, psychotic disorders, myokymia, seizures, epilepsy, seizure, retinal degeneration, hearing and vision loss, Alzheimer's disease, age-related memory loss, learning deficiencies, anxiety, neuronal degeneration and motor neuron diseases, maintaining bladder control or treating urinary incontinence) and as neuroprotective agents (e.g., to prevent stroke and the like) by modulating potassium channels associated with the onset or recurrence of the indicated conditions.